BSECompany Update7 Oct 2026 · 7 Oct 2026, 06:35 pm

Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018

Cohance Lifesciences Ltd · 543064

✦ AI SummaryRegulatory

Cohance Lifesciences Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30 September 2026, confirming the details of securities dematerialized/rematerialized during the period.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cohance Lifesciences Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

380a8b5e-dd5f-478d-b973-3589f82f3270.pdf

pdf

Download →
View document text
7 October 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400001 Bandra (E), Mumbai – 400051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 September 2026 Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation Certificates issued by KFin Technologies Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended 30 September 2026. This is for your information and record. Thanking you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K Mishra Company Secretary and Compliance Officer Encl: as above KFIN/SUVE/CDSL/74(5) E/1 Date: 02‐10‐2026 CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED REGD OFF: MARATHON FUTUREX, A WING 25TH FLOOR NM JOSHI MARG LOWER PAREL (EAST) MUMBAI ‐ 400 023 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the COHANCE LIFESCIENCES LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: COHANCE LIFESCIENCES LIMITED 215 ATRIUM C WING 8TH FLOOR, 819‐821 ANDHERI KURLA ROAD CHAKALA ANDHERI EAST CHAKALA MIDC MUMBAI 400093 KFIN/SUVE/NSDL/74(5) E/1 Date: 02‐10‐2026 NATIONAL SECURITIES DEPOSITORY LIMITED TRADE WORLD 4TH FLOOR KAMALA MILLS COMPOUND SENAPATI BAPAT MARG LOWER PAREL MUMBAI ‐ 400 013 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the COHANCE LIFESCIENCES LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: COHANCE LIFESCIENCES LIMITED 215 ATRIUM C WING 8TH FLOOR, 819‐821 ANDHERI KURLA ROAD CHAKALA ANDHERI EAST CHAKALA MIDC MUMBAI 400093